Profile
Hennie R.
Hoogenboom is Chief Scientific Officer of Ablynx NV.
He was Senior Vice President of Dyax.
He received a PhD from Catholic University.
Former positions of Hennie R. Hoogenboom
| Companies | Position | End |
|---|---|---|
| ABLYNX | Chief Tech/Sci/R&D Officer | - |
Training of Hennie R. Hoogenboom
| Université Libre de Bruxelles | Undergraduate Degree |
| Université Catholique de Louvain | Doctorate Degree |
Experiences
Positions held
Connections
33
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Hennie R. Hoogenboom